Legal Opinion
Coleson v. Janssen Pharmaceutical, Inc.
District Court, S.D. New York
Decided May 3, 2017No. 15 Civ. 4792 (RWS)PublishedCited by 8 opinions
1Opinion of the Court
OPINION
Sweet, D.J.
Defendants Janssen Pharmaceuticals, Inc. and Johnson & Johnson (collectively, “Janssen” or the. “Defendants”) have moved pursuant to Fed. R. Civ. P. 56 for summary judgment dismissing the complaint of Plaintiff Samuel Coleson, Jr. (“Coleson” or,the “Plaintiff’). As set forth below, the motion is granted.
Prior Proceedings
On April 23, 2015, Coleson filed a pro se complaint against Defendants in the Supreme Court, Bronx County, which alleged that he developed gynecomastia as a result of taking Risperdal and generic risperi-done. On June 18, 2015, Janssen properly removed the…
2Cases cited19 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Erie Railroad v. TompkinsSupreme Court of the United States · 1938
- Nikitas Amorgianos v. National Railroad Passenger CorporationCourt of Appeals for the Second Circuit · 2002
- Fletcher v. Atex, Inc.Court of Appeals for the Second Circuit · 1995
- Voss v. Black & Decker Manufacturing Co.New York Court of Appeals · 1983
14 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Trisvan v. HeymanDistrict Court, E.D. New York · 2018
- Delgado v. Universal Beauty Products, Inc.District Court, E.D. New York · 2022
- Gallagher v. Boehringer Ingelheim Pharmaceuticals, Inc.District Court, S.D. New York · 2023
- Gallego v. Tandem Diabetes Care, Inc.District Court, E.D. New York · 2025
- Montero v. Teva Pharmaceuticals USA Inc.District Court, S.D. New York · 2019
3 more not listed; retrieve them via the Exa API.